Table 4 Summary of reduction factors of three disinfectants against Nipah virus, Ebola virus and SARS-CoV-2.
From: Evaluation and comparison of three virucidal agents on inactivation of Nipah virus
Test products | Concentrations | Nipah virus | Ebola virus | SARS-CoV-2 | |||
|---|---|---|---|---|---|---|---|
Contact time period | RF | Contact time period | RF | Contact time period | RF | ||
MCP | 5% | ND | ND | > 15 s | > 4 | > 15 s | > 4 |
1.67% (5%/3) | > 15 s | > 4 | > 15 s | > 4 | > 15 s | > 4 | |
0.56% (5%/9) | > 15 s | > 4 | > 15 s | > 4 | > 15 s | > 4 | |
0.19% (5%/27) | > 1 min | > 4 | > 1 min | > 4 | > 1 min | > 4 | |
0.06% (5%/81) | 8 min | < 4 | 8 min | < 4 | 8 min | > 4 | |
FWD | 5% | ND | ND | > 15 s | > 4 | > 15 s | > 4 |
1.67% (5%/3) | > 15 s | > 4 | > 15 s | > 4 | > 15 s | > 4 | |
0.56% (5%/9) | > 15 s | > 4 | > 1 min | > 4 | > 15 s | > 4 | |
0.19% (5%/27) | > 15 s | > 4 | > 2 min | > 4 | > 30 s | > 4 | |
0.06% (5%/81) | 8 min | < 4 | 8 min | < 4 | 8 min | < 4 | |
MCP-1W | 5% | > 15 s | > 4 | > 15 s | > 4 | > 15 s | > 4 |
1.67% (5%/3) | > 15 s | > 4 | > 4 min | > 4 | > 30 s | > 4 | |
0.56% (5%/9) | > 15 s | > 4 | 8 min | < 4 | > 1 min | > 4 | |
0.19% (5%/27) | > 1 min | > 4 | 8 min | < 4 | > 2 min | > 4 | |
0.06% (5%/81) | ND | ND | ND | ND | 8 min | > 4 | |
FWD-1W | 5% | > 15 s | > 4 | > 30 s | > 4 | > 15 s | > 4 |
1.67% (5%/3) | > 30 s | > 4 | 8 min | > 4 | > 1 min | > 4 | |
0.56% (5%/9) | > 30 s | > 4 | 8 min | < 4 | > 1 min | > 4 | |
0.19% (5%/27) | > 1 min | > 4 | 8 min | < 4 | > 2 min | > 4 | |
0.06% (5%/81) | ND | ND | ND | ND | 8 min | < 4 | |
Medical EtOH (95%) | 95% | ND | ND | > 15 s | > 4 | > 15 s | > 4 |
76% | > 15 s | > 4 | > 15 s | > 4 | > 15 s | > 4 | |
57% | > 15 s | > 4 | > 15 s | > 4 | > 15 s | > 4 | |
38% | > 15 s | > 4 | > 15 s | > 4 | > 15 s | > 4 | |
19% | 8 min | > 4 | 8 min | < 4 | 8 min | < 4 | |
